Special supplement for patients with cancer at risk of malnutrition
Part of Digestive system clinical trials.
This trial tests a special liquid supplement for patients with head, neck, lung, rectal, or esophageal cancer who are having radiation and are malnourished or at risk. The supplement is designed to be easier to digest if you have stomach or gut issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have head, neck, lung, rectal, or esophageal cancer and are starting or already on radiation therapy
- You are malnourished or at risk of malnutrition
- You have trouble digesting regular liquid supplements and need a special easy-to-digest type
- You can answer questions about your health and agree to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a nutritional supplement drink can help people with cancer who are at risk of not getting enough nutrients. It aims to see if the supplement supports strength and well-being during cancer treatment.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This trial tests whether a special nutritional drink can help people with advanced gastrointestinal cancer better tolerate their first chemotherapy or other systemic treatment, possibly reducing side effects and improving quality of life.
This trial studies whether a nutritional supplement helps people with head and neck squamous cell cancer when they are receiving radiation (with or without chemotherapy). You must be able to eat by mouth and have specific cancer types and recent CT imaging.
This trial tests whether a special nutrition supplement (rich in EPA, an omega-3 fat) can help people with advanced lung or colorectal cancer who are losing weight. It aims to improve treatment outcomes and quality of life.
Hear when a new Oncological Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.